Iztok Grabnar

3.5k total citations
111 papers, 2.8k citations indexed

About

Iztok Grabnar is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Iztok Grabnar has authored 111 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pediatrics, Perinatology and Child Health, 19 papers in Pharmaceutical Science and 17 papers in Molecular Biology. Recurrent topics in Iztok Grabnar's work include Pharmacological Effects and Toxicity Studies (18 papers), Epilepsy research and treatment (14 papers) and Advanced Drug Delivery Systems (12 papers). Iztok Grabnar is often cited by papers focused on Pharmacological Effects and Toxicity Studies (18 papers), Epilepsy research and treatment (14 papers) and Advanced Drug Delivery Systems (12 papers). Iztok Grabnar collaborates with scholars based in Slovenia, Italy and Serbia. Iztok Grabnar's co-authors include Tomaž Vovk, Aleš Mrhar, Boštjan Martinc, Blanka Kores Plesničar, Beatrice Perissutti, Vita Dolžan, Igor Locatelli, Marija Bošković, Dario Voinovich and Stefano Dall’Acqua and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Iztok Grabnar

109 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iztok Grabnar Slovenia 30 538 411 380 350 298 111 2.8k
Ulf Bondesson Sweden 33 674 1.3× 416 1.0× 635 1.7× 685 2.0× 116 0.4× 156 3.8k
Andrew Fitton United Kingdom 34 758 1.4× 300 0.7× 560 1.5× 274 0.8× 155 0.5× 53 4.1k
Ana Fortuna Portugal 34 1.0k 1.9× 438 1.1× 446 1.2× 179 0.5× 958 3.2× 128 3.7k
Swapnil Sharma India 28 684 1.3× 110 0.3× 325 0.9× 178 0.5× 358 1.2× 242 3.6k
W. Meuldermans Belgium 30 590 1.1× 343 0.8× 350 0.9× 871 2.5× 204 0.7× 70 2.8k
Arthur B. Straughn United States 26 204 0.4× 373 0.9× 460 1.2× 271 0.8× 324 1.1× 71 2.1k
Fatemeh Akhlaghi United States 34 846 1.6× 519 1.3× 172 0.5× 536 1.5× 70 0.2× 105 3.8k
Michael Mayersohn United States 34 837 1.6× 314 0.8× 197 0.5× 692 2.0× 443 1.5× 160 3.8k
Gilberto Alves Portugal 37 1.3k 2.4× 533 1.3× 554 1.5× 280 0.8× 932 3.1× 191 5.3k
Nuggehally R. Srinivas India 32 903 1.7× 158 0.4× 243 0.6× 488 1.4× 156 0.5× 254 3.4k

Countries citing papers authored by Iztok Grabnar

Since Specialization
Citations

This map shows the geographic impact of Iztok Grabnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iztok Grabnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iztok Grabnar more than expected).

Fields of papers citing papers by Iztok Grabnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iztok Grabnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iztok Grabnar. The network helps show where Iztok Grabnar may publish in the future.

Co-authorship network of co-authors of Iztok Grabnar

This figure shows the co-authorship network connecting the top 25 collaborators of Iztok Grabnar. A scholar is included among the top collaborators of Iztok Grabnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iztok Grabnar. Iztok Grabnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roškar, Robert, et al.. (2025). Additive effects of the new viscosity-reducing and stabilizing excipients for monoclonal antibody formulation. International Journal of Pharmaceutics. 674. 125451–125451. 3 indexed citations
2.
3.
Locatelli, Igor, et al.. (2024). Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis. Redox Biology. 77. 103380–103380. 27 indexed citations
4.
Grabnar, Iztok, et al.. (2024). Machine learning driven bioequivalence risk assessment at an early stage of generic drug development. European Journal of Pharmaceutics and Biopharmaceutics. 205. 114553–114553.
5.
Grabnar, Iztok, et al.. (2024). Association between Prescribing and Intoxication Rates for Selected Psychotropic Drugs: A Longitudinal Observational Study. Pharmaceuticals. 17(1). 143–143. 2 indexed citations
6.
7.
8.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2021). Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model. Pharmaceutics. 13(10). 1587–1587. 17 indexed citations
9.
Hasa, Dritan, Simon Žakelj, Iztok Grabnar, et al.. (2020). Echinacea angustifolia DC. Lipophilic Extract Patch for Skin Application: Preparation, In Vitro and In Vivo Studies. Pharmaceutics. 12(11). 1096–1096. 4 indexed citations
10.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2020). Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission. Clinical Gastroenterology and Hepatology. 19(1). 111–118.e10. 32 indexed citations
11.
Horvat, Nejc, Mitja Kos, Aleš Obreza, et al.. (2017). Curriculum Mapping of the Master’s Program in Pharmacy in Slovenia with the PHAR-QA Competency Framework. SHILAP Revista de lepidopterología. 5(2). 24–24. 5 indexed citations
12.
Sut, Stefania, Marta Faggian, Valeria Baldan, et al.. (2017). Natural Deep Eutectic Solvents (NADES) to Enhance Berberine Absorption: An In Vivo Pharmacokinetic Study. Molecules. 22(11). 1921–1921. 94 indexed citations
13.
Perry, Miranda L., Matteo Lusi, Michele R. Chierotti, et al.. (2016). Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization. Journal of Pharmaceutical Sciences. 105(12). 3626–3633. 36 indexed citations
14.
Grabnar, Iztok, et al.. (2015). Febrile neutropenia in chemotherapy treated small-cell lung cancer patients. Radiology and Oncology. 49(2). 173–180. 9 indexed citations
15.
Plesničar, Blanka Kores, Alessandro Serretti, Laura Mandelli, et al.. (2010). MDR1 gene polymorphisms and response to acute risperidone treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(2). 387–392. 30 indexed citations
16.
17.
Grabnar, Iztok, Igor Locatelli, Samo Andrenšek, et al.. (2009). Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423—a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity. Drug Development and Industrial Pharmacy. 35(11). 1293–1304. 10 indexed citations
18.
Grosek, Štefan, Alojz Ihan, Branka Wraber, et al.. (2007). Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair. Clinical Chemistry and Laboratory Medicine (CCLM). 45(10). 1366–72. 5 indexed citations
19.
Voinovich, Dario, Mariarosa Moneghini, Beatrice Perissutti, Jelena Filipović‐Grčić, & Iztok Grabnar. (2000). Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. International Journal of Pharmaceutics. 203(1-2). 235–244. 59 indexed citations
20.
Karba, R., et al.. (1999). Some artificial intelligence and control approaches to pharmacokinetic-pharmacodynamic modelling. Systems Analysis Modelling Simulation. 35(1). 75–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Bondesson Breakdown of academic impact, for papers by Andrew Fitton Breakdown of academic impact, for papers by Ana Fortuna Breakdown of academic impact, for papers by Swapnil Sharma Breakdown of academic impact, for papers by W. Meuldermans Breakdown of academic impact, for papers by Arthur B. Straughn Breakdown of academic impact, for papers by Fatemeh Akhlaghi Breakdown of academic impact, for papers by Michael Mayersohn Breakdown of academic impact, for papers by Gilberto Alves Breakdown of academic impact, for papers by Nuggehally R. Srinivas
Rankless by CCL
2026